Transposon mutagenesis identifies genetic drivers of Braf V600E melanoma

Michael B. Mann, Michael A. Black, Devin J. Jones, Jerrold M. Ward, Christopher Chin Kuan Yew, Justin Y. Newberg, Adam J. Dupuy, Alistair G. Rust, Marcus W. Bosenberg, Martin Mcmahon, Cristin G. Print, Neal G. Copeland, Nancy A. Jenkins

Research output: Contribution to journalArticle

36 Scopus citations

Abstract

Although nearly half of human melanomas harbor oncogenic BRAF V600E mutations, the genetic events that cooperate with these mutations to drive melanogenesis are still largely unknown. Here we show that Sleeping Beauty (SB) transposon-mediated mutagenesis drives melanoma progression in Braf V600E mutant mice and identify 1,232 recurrently mutated candidate cancer genes (CCGs) from 70 SB-driven melanomas. CCGs are enriched in Wnt, PI3K, MAPK and netrin signaling pathway components and are more highly connected to one another than predicted by chance, indicating that SB targets cooperative genetic networks in melanoma. Human orthologs of >500 CCGs are enriched for mutations in human melanoma or showed statistically significant clinical associations between RNA abundance and survival of patients with metastatic melanoma. We also functionally validate CEP350 as a new tumor-suppressor gene in human melanoma. SB mutagenesis has thus helped to catalog the cooperative molecular mechanisms driving BRAF V600E melanoma and discover new genes with potential clinical importance in human melanoma.

Original languageEnglish (US)
Pages (from-to)486-495
Number of pages10
JournalNature Genetics
Volume47
Issue number5
DOIs
StatePublished - May 30 2015

ASJC Scopus subject areas

  • Genetics

Fingerprint Dive into the research topics of 'Transposon mutagenesis identifies genetic drivers of Braf V600E melanoma'. Together they form a unique fingerprint.

Cite this